41 Results for "

dasatinib

" in MedChemExpress (MCE) Product Catalog:
Products (41)

41 Results for "dasatinib" in MCE Product Catalog:

179
179 Publications Verification
Cat. No.: HY-10181
CAS No.: 302962-49-8
Purity:  99.83%
Synonyms: BMS-354825
Dasatinib (BMS-354825) is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity. The Kis are 16 pM and 30 pM for Src and Bcr-Abl, respectively. Dasatinib inhibits Bcr-Abl and Src with IC50s of <1.0 nM and 0.5 nM, respectively. Dasatinib also induces apoptosis and autophagy, and can cross the blood-brain barrier .
loading...
    loading...
179
179 Publications Verification
Cat. No.: HY-10181A
CAS No.: 854001-07-3
Purity:  98.86%
Synonyms: BMS-354825 hydrochloride
Research Areas:  

Cancer

Dasatinib (BMS-354825) hydrochloride is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity. The Kis are 16 pM and 30 pM for Src and Bcr-Abl, respectively. Dasatinib hydrochloride inhibits Bcr-Abl and Src with IC50s of <1.0 nM and 0.5 nM, respectively . Dasatinib hydrochloride also induces apoptosis and autophagy.
loading...
    loading...
179
179 Publications Verification
Cat. No.: HY-10181B
CAS No.: 863127-77-9
Purity:  99.58%
Synonyms: BMS-354825 monohydrate
Research Areas:  

Cancer

Dasatinib (BMS-354825) monohydrate is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity. The Kis are 16 pM and 30 pM for Src and Bcr-Abl, respectively. Dasatinib monohydrate inhibits Bcr-Abl and Src with IC50s of <1.0 nM and 0.5 nM, respectively . Dasatinib monohydrate also induces apoptosis and autophagy.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-10181S
CAS No.: 1132093-70-9
Purity:  98.17%
Synonyms: BMS-354825-d8
Dasatinib-d8 (BMS-354825-d8) is a deuterium labeled Dasatinib. Dasatinib is a dual Bcr-Abl and Src family tyrosine kinase inhibitor.
loading...
    loading...
Cat. No.: HY-131669
CAS No.: 910297-53-9
Purity:  99.64%
Synonyms: dasatinib carboxylic acid
Dasatinib metabolite M6 (Dasatinib carboxylic acid) is a circulating metabolite of Dasatinib (HY-10181). Dasatinib exhibits potent anti-tumor activity .
loading...
    loading...
Cat. No.: HY-107447
CAS No.: 910297-51-7
Purity:  98.58%
Synonyms: N-Deshydroxyethyl BMS-354825
N-Deshydroxyethyl Dasatinib (N-Deshydroxyethyl BMS-354825) is a metabolite of Dasatinib, Dasatinib is a multi-kinase inhibitor that potently inhibits Bcr-Abl, Src family and platelet-derived growth factor receptor kinases. N-Deshydroxyethyl Dasatinib can be used in cancer and immune disease research .
loading...
    loading...
Cat. No.: HY-137345
CAS No.: 2769753-64-0
Purity:  98.03%
DB-3-291 is a CSK-targeting agent with a human CSK Kd of 1 nM and high selectivity for CSK over other kinases bound by dasatinib. DB-3-291 induces targeted degradation of CSK via a ubiquitin-dependent pathway and incorporates dasatinib as the kinase binding ligand. DB-3-291 can be used for the research of innate immune responses to viral DNA .
loading...
    loading...
Cat. No.: HY-176461
CAS No.: 2468065-01-0
Target:  

Src Bcr-Abl

Research Areas:  

Cancer

Pro-Dasatinib (compound 2j), an amino acid analog of Dasatinib (HY-10181), is a potent Src/Abl kinase inhibitor. Pro-Dasatinib has antiproliferative activity against K652 leukemia cancer cells with an IC50 of 0.21 nM.
loading...
    loading...
Cat. No.: HY-111857
CAS No.: 2112837-79-1
Purity:  98.04%
Synonyms: BMS-354825 carbaldehyde; PROTAC ABL binding moiety 4
Research Areas:  

Cancer

Dasatinib carbaldehyde (BMS-354825 carbaldehyde), the Dasatinib (ABL inhibitor) based moiety, binds to IAP ligand via a linker to form SNIPER .
loading...
    loading...
Cat. No.: HY-170851
Target:  

Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

GL392 is a senolytic agent that selectively delivers the potent senolytic compound Dasatinib (HY-10181) to senescent cells. GL392 targets lipofuscin in senescent cells via the LBD domain and is linked to Dasatinib through an ester bond. Upon internalization in senescent cells, Dasatinib is released, inducing apoptosis of the senescent cells. GL392 in micelle encapsulation (mGL392) enables selective delivery to senescent cells, achieving selective senescent cell elimination in vitro and in vivo. GL392 can be used for the research of melanoma .
loading...
    loading...
Cat. No.: HY-133794
CAS No.: 910297-52-8
Purity:  99.27%
Target:  

Drug Metabolite

Research Areas:  

Cancer

Dasatinib N-oxide is a minor metabolite of Dasatinib. Dasatinib is a potent and orally active dual Src/Bcr-Abl inhibitor .
loading...
    loading...
Cat. No.: HY-10181R
CAS No.: 302962-49-8
Synonyms: BMS-354825 (Standard)
Research Areas:  

Cancer

Dasatinib (Standard) is the analytical standard of Dasatinib. This product is intended for research and analytical applications. Dasatinib (BMS-354825) is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity. The Kis are 16 pM and 30 pM for Src and Bcr-Abl, respectively. Dasatinib inhibits Bcr-Abl and Src with IC50s of <1.0 nM and 0.5 nM, respectively . Dasatinib also induces apoptosis and autophagy.
loading...
    loading...
Cat. No.: HY-10181S1
CAS No.: 1160297-08-4
Synonyms: BMS-354825-d4
Dasatinib-d4 (BMS-354825-d4) is deuterium labeled Dasatinib. Dasatinib (BMS-354825) is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity. The Kis are 16 pM and 30 pM for Src and Bcr-Abl, respectively. Dasatinib inhibits Bcr-Abl and Src with IC50s of <1.0 nM and 0.5 nM, respectively . Dasatinib also induces apoptosis and autophagy.
loading...
    loading...
Cat. No.: HY-176049
CAS No.: 3079237-53-6
Target:  

Drug Derivative

Research Areas:  

Neurological Disease

Dasatinib derivative 1 (2e) effectively releases NO and increases the concentration of 3′,5′-cyclic guanosine monophosphate, as well as maintains senolytic activity. Dasatinib derivative 1 (2e) can be used in the research for chronic ocular hypertension (COHT) glaucoma .
loading...
    loading...
Cat. No.: HY-176462
CAS No.: 2102305-55-3
Target:  

Drug Derivative

Research Areas:  

Cancer

Gly-Dasatinib (compound I-7-1), an amino acid analog of Dasatinib (HY-10181), is a tyrosine kinase inhibitor. Gly-Dasatinib can be used for the study of cancer .
loading...
    loading...
Cat. No.: HY-133794S
CAS No.: 1189988-36-0
Dasatinib N-oxide-d8 is the deuterium labeled Dasatinib N-oxide. Dasatinib N-oxide is a minor metabolite of Dasatinib. Dasatinib is a potent and orally active dual Src/Bcr-Abl inhibitor .
loading...
    loading...
Cat. No.: HY-156883
CAS No.: 1174416-41-1
Purity:  98.08%
Target:  

Cytochrome P450

Research Areas:  

Others

Dasatinib analog-1 (compound 5826) inhibits CYP3A4 viability with a Ki value of 5.4 μM. Dasatinib analog-1 blocks the formation of glutathione adducts .
loading...
    loading...
Cat. No.: HY-W700620
CAS No.: 910297-58-4
Research Areas:  

Inflammation/Immunology

Hydroxymethyl dasatinib (M24), a benzylhydroxy metabolite of Dasatinib (HY-10181), exhibits an IC50 of 46.7nM in K562 CML cells .
loading...
    loading...
Cat. No.: HY-111872
CAS No.: 3093563-31-3
Purity:  99.79%
Target:  

SNIPERs Bcr-Abl

Research Areas:  

Cancer

SNIPER(ABL)-020, conjugating Dasatinib (ABL inhibitor) to Bestatin (IAP ligand) with a linker, induces the reduction of BCR-ABL protein .
loading...
    loading...
Cat. No.: HY-161687
CAS No.: 3049801-09-1
Target:  

Src

Research Areas:  

Cancer

Cisplatin/Dasatinib prodrug-1 (Compound 3) is a prodrug of Cisplatin (HY-17394) and Dasatinib (HY-10181). Cisplatin/Dasatinib prodrug-1 exhibits antiproliferative activity against A2780, MDA-MB-231, MCF7, HCT116, RD, Thp1 and HL60 cancer cells with IC50s of 0.1, 0.1, 0.36, 2.0, 0.4, 0.3 and 0.25 μM, respectively .
loading...
    loading...